GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare fat disorder
Disease control CompletedThis study tested an experimental drug called REGN4461 in 16 people with generalized lipodystrophy, a rare condition where the body can't store fat properly, leading to severe metabolic problems. The drug aims to improve blood sugar and triglyceride levels. Participants received …
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Rare fat disorder drug under microscope: new safety data emerges
Disease control CompletedThis study looked at the safety of a daily shot called metreleptin (brand name Myalept) in 11 people with generalized lipodystrophy, a rare condition where the body loses fat tissue. The main goal was to see if the body makes antibodies against the drug, which could affect how we…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE4 • Sponsor: Aegerion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC